A Wall Street analyst projected that Viking Therapeutics' stock could rise by 188%. The bold forecast signals strong investor confidence in the biotech firm's prospects and may influence trading activity. Wall Street analyst,Viking Therapeutics Investors may monitor the stock for reactions, and the analyst could issue follow‑up commentary as new data emerges. An analyst from Wall Street has issued a bold prediction regarding Viking Therapeutics, suggesting that the company's stock could rise by 188%. This projection is noteworthy amid fluctuations in the broader market, indicating potential investor confidence in Viking's future prospects.
Social Pulse
AI estimate · not scraped